Search Results - "Criscuolo, Clelia"

PubPharm (15)

1

Immune reactivity during COVID-19 : Implications for treatment

in: Immunology letters | Vol. 231 (2021), p. 28-34

by Napoli, C. | Benincasa, G. | Criscuolo, C. | +3

2

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma : Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

in: Haematologica | Vol. 106, No. 1 (2021), p. 291-294

by Gentile, M. | Specchia, G. | Derudas, D. | +53

3

More on spontaneous regression of chronic lymphocytic leukemia : two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection

in: Leukemia & lymphoma | Vol. 55, No. 8 (2014), p. 1955-7

by D'Arena, G. | Guariglia, R. | Pietrantuono, G. | +7

CommentOn: Leuk Lymphoma. 2013 Aug;54(8):1647-51. - PMID 23185961

4

More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection

in: Leukemia & lymphoma | Vol. 55, No. 8 (2014), p. 1955-1957

by D'Arena, G. | Guariglia, R. | Pietrantuono, G. | +7

5

Primary extranodal non-Hodgkin's lymphoma of the vagina : a case report and a review of the literature

in: Acta haematologica | Vol. 128, No. 1 (2012), p. 33-8

by Guastafierro, S. | Tedeschi, A. | Criscuolo, C. | +4

6

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

in: Hematological oncology | Vol. 29, No. 3 (2011), p. 139-43

by Ferrara, F. | Izzo, T. | Criscuolo, C. | +5

7

Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia : feasibility, toxicity, and therapeutic results

in: American journal of hematology | Vol. 85, No. 9 (2010), p. 687-90

by Ferrara, F. | Izzo, T. | Criscuolo, C. | +3

8

Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission

in: Anticancer research | Vol. 30, No. 9 (2010), p. 3845-9

by Ferrara, F. | Finizio, O. | Izzo, T. | +5

9

Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan

in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | Vol. 16, No. 7 (2010), p. 1018-24

by Ferrara, F. | Izzo, T. | Criscuolo, C. | +5

10

Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome

in: Hematological oncology | Vol. 28, No. 4 (2010), p. 202-8

by Ferrara, F. | Palmieri, S. | Izzo, T. | +2